Robotics & Automation News

Where Innovation Meets Imagination

cardiovascular

Microsurgery robot market to play ‘key role’ in advanced cardiovascular diseases and cancer treatments

by

The microsurgery robot market is predicted to play “key role” in advanced coronavirus and cancer treatments, according to research by Global Market Insights.

The US microsurgery robot market accounted for $355.1 million in 2017, owing to increasing incidence of cardiovascular, neurovascular, oncology and other chronic diseases.

The increasing prevalence of chronic disease will favor industry growth in the region. Favorable healthcare and reimbursement policies coupled with adoption of technologically advanced microsurgery robots will promote revenue generation in the future. [Read more…] about Microsurgery robot market to play ‘key role’ in advanced cardiovascular diseases and cancer treatments

Corindus shows CorPath GRX System at cardiovascular conference

by

Corindus Vascular Robotics, Inc., a developer of precision vascular robotics, featured its CorPath GRX System at the recent Transcatheter Cardiovascular Therapeutics (TCT) 2018 Conference in California, USA.

Corindus’ CorPath GRX is the first FDA-cleared medical device for robotic-assisted vascular interventions.

“There has been tremendous progress made in the development of our robotic platform, including procedural automation and remote technology, which we believe will have the power to change the treatment paradigm and increase patient access to care,” said J. Aaron Grantham, M.D., Cardiovascular Chief Medical Officer of Corindus.

[Read more…] about Corindus shows CorPath GRX System at cardiovascular conference